Finland· FI-REL-REL2521
Tracel
A elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente product containing chromium chloride hexahydrate + copper chloride dihydrate + ferric chloride hexahydrate + manganese chloride tetrahydrate + 5 more, registered in Finland by Fresenius Kabi AB. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente is registered in 11 of 19 countries.
Countries holding a registration under ATC B05XA31 (elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · ATC B05XA31
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Chromium chloride hexahydrate + Copper chloride dihydrate + Ferric chloride hexahydrate + Manganese chloride tetrahydrate + 5 more
- Manufacturer
- Fresenius Kabi AB
- Country
- Finland (FI)
- ATC code
- B05XA31
- ATC class
- Elektrolyte, Kombinationen mit anderen Arzneistoffen, inkl. reine Spurenelemente
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
102 interactions on record for elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente · interactions on record
102 records
- 4 severe
- 12 moderate
- 86 minor
Most severe, free to view
- RaltegravirJ05AJ01severe
- ElvitegravirJ05AJ02severe
- RaltegravirJ05AX08severe
- ElvitegravirJ05AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf22ca50-9561-4e46-aa6f-96a247c740c3 GET /v1/drugs/bf22ca50-9561-4e46-aa6f-96a247c740c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "infuusiokonsentraatti, liuosta varten",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "elektrolyyttien ja muiden lääkeaineiden yhdistelmävalmisteet",
"ma_number": "9988",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL2521",
"authorised_at": "1989-05-31"
}See everything about elektrolyte, kombinationen mit anderen arzneistoffen, inkl. reine spurenelemente.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.